FOYA Program

Supplement [PDF] Eli Lilly and Company Overall Winner, Facility of the Future Location: Indianapolis, Indiana, USA and Carolina, Puerto Rico Project: Continuous Direct Compression Manufacturing Kits 2 & 3 Cook Pharmica...
Media & Press Releases
29 October 2025
CSL Behring has been honored with this prestigious award recognizing innovation and excellence in pharmaceutical facility projects, as the FOYA program celebrates its 20th anniversary ISPE has recognized CSL Behring as the Overall Winner of the 2025...
Media & Press Releases
13 November 2025
Each year, ISPE honors innovative and impactful pharmaceutical facilities through the ISPE Facility of the Year Awards (FOYA) program. In the article that follows, Scott Billman, Senior Vice President of Global Engineering, Technology, and Facilities...
iSpeak Blog

Bayer, a global leader in the pharmaceutical industry, is committed to advancing healthcare through innovative solutions. With their new Cell Therapy Launch and Manufacturing Facility, Bayer aims to provide hope to patients with unmet medical needs by finding a cure and making life-changing therapies more accessible to all. The facility signifies a major advancement in the production and...

iSpeak Blog

Sanofi Toronto manufactures and distributes up to 100 million pediatric and adult vaccines for infectious diseases such as diphtheria, pertussis, tetanus each year. The Toronto site has been in continuous operation since 1914 and consists of more than 30 buildings across a 52-acre site. Sanofi is a leading research and development company and the largest vaccine producer in Canada, protecting...

Media & Press Releases
19 September 2025
CSL Behring is a 2025 ISPE Facility of the Year Awards (FOYA) category winner. The article that follows features an interview with Anthony Kaye, Senior Director of Base Fractionation at CSL Behring, on CSL Behring's unique initiative, Project Aurora...
iSpeak Blog

Johnson & Johnson Innovative Medicine, part of the Johnson & Johnson family of companies, develops innovative and integrated products and medicines to restore and extend the quality of life for patients globally. The expansion of Johnson & Johnson’s BioCork facility in Ringaskiddy, Cork, Ireland increased the existing biomanufacturing capacity at the plant while also creating...

iSpeak Blog

Johnson & Johnson’s facility in Latina, Italy, is a small molecule manufacturing site for global launches and commercial supply of solid dosage forms. It is also the strategic launch and growth site for manufacturing and packaging of solids products. Johnson & Johnson Latina site’s diverse portfolio includes multiple therapeutic areas.

iSpeak Blog
According to the Organ Procurement and Transplant Network (OPTN), every 10 minutes, one new person joins the organ recipient waiting list. As of the end of June 2025, more than 100,000 were on OPTN’s waiting list in the US. Traditionally, FOYA winning facilities are focused on the manufacturing of clinical or commercial products and research lab facilities enabling discovery of medicine.
Off
This facility is expected to significantly improve the lives of patient populations by facilitating development of innovative therapies. For example, BlueRock Therapeutics is currently differentiating stem cells into...